P916: Small bowel permeability improvement is associated with microbial changes seen in mild to moderate active paediatric Crohn's disease patients on nutritional therapyECCO’23 CopenhagenYear: 2023
Authors: VerburgtMD, C.(1,2)*;Dunn, K.(3);Sigall Boneh, R.(4);Wine, E.(5);Benninga, M.(1);de Jonge, W.(2,6);Van Limbergen, J.(1,2);
(1)Emma Children's Hospital- Amsterdam University Medical Centers, Dpt of Paediatric Gastroenterology and Nutrition, Amsterdam, The Netherlands;(2)Amsterdam Gastroenterology Endocrinology Metabolism- University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, Amsterdam, The Netherlands;(3)Dalhousie University, Dpt of Biology, Halifax, Canada;(4)Sackler Faculty of Medicine- Tel Aviv University, Wolfson Medical Center, Tel Aviv, Israel;(5)Stollery Children's Hospital- University of Alberta, Division of Paediatric Gastroenterology, Edmonton, Canada;(6)University of Bonn, Dpt of Surgery, Bonn, Germany;
P917: Intestinal complement interacts with commensal microbiota and provides pattern recognition in Inflammatory Bowel DiseaseECCO’23 CopenhagenYear: 2023
Authors: Reider, S.(1)*;Posch, W.(2);Koch, R.(3);Orth-Höller, D.(4);Würzner, R.(2);Wilflingseder, D.(2);Tilg, H.(3);Moschen, A.(1);
(1)Johannes Kepler University and Kepler University Hospital, Department of Internal Medicine 2 - Gastroenterology and Hepatology, Linz, Austria;(2)Medical University Innsbruck, Department for Hygiene- Microbiology and Public Health, Innsbruck, Austria;(3)Medical University Innsbruck, Department of Internal Medicine I, Innsbruck, Austria;(4)MB-LAB, Mikrobiologisches Labor, Innsbruck, Austria;
P918: Clostridium butyricum inhibits epithelial-mesenchymal transition of intestinal carcinogenesis through downregulating METTL3ECCO’23 CopenhagenYear: 2023
Authors: Zhang, K.(1)*;Dong, Y.(1);Li, M.(1);Zhang, W.(1);Ding, Y.(1);Wang, X.(1);Chen, D.(1);Liu, T.(1);Wang, B.(1);Zhong, W.(1);Cao, H.(1)*;
(1)General Hospital- Tianjin Medical University- National Key Clinical Specialty- Tianjin Institute of Digestive Diseases- Tianjin Key Laboratory of Digestive Diseases, Department of Gastroenterology and Hepatology, Tianjin, China;
P919: Gut microbial signature and phenotype-specific Indicators in fecal microbiota of Korean patients with Inflammatory Bowel DiseaseECCO’23 CopenhagenYear: 2023
Authors: Lee, C.K.(1)*;Oh, S.J.(1);Kim, H.J.(1);Kim, B.H.(2);Kim, B.K.(3);Park, Y.K.(3);Yang, B.G.(3);
(1)Kyung Hee University, Gastroenterology, Seoul, Korea- Republic Of;(2)Kyung Hee University, Clinical Pharmacology and Therapeutics, Seoul, Korea- Republic Of;(3)GI Biome Inc., Research Institute, Seongnam, Korea- Republic Of;
P920: Gut microbiota at diagnosis is associated with clinical features and future disease course in Inflammatory Bowel Disease: Data from IBSEN III, a new large Norwegian population-based inception cohortECCO’23 CopenhagenYear: 2023
Authors: Hyll Hansen, S.(1,2,3)*;Gjerstad Maseng, M.(3,4,5);Björkqvist, O.(6);Halfvarsson, J.(7);Bang, C.(8);Detlie, T.E.(9,10);Huppertz-Hauss, G.(11);Kristensen, V.(5,12);Opheim, R.(5,13);Perminow, G.(14);Asak, Ø.(15);Bengtson, M.B.(10);Boyar Cetinkaya, R.(16);Henriksen, M.(17);Hovde, Ø.(3,18);Medhus, A.W.(3,5);Pallenschat, J.(19);Strande, V.(3,20,21);Valeur, J.(21);Svendsen Vatn, S.(10);Bergene Aabrekk, T.(22);Høivik, M.L.(5);Hov, J.R.(1,2,3,23);
(1)Oslo University Hospital, Norwegian PSC Research Center- Department of Transplantation Medicine- Division of Surgery- Inflammatory Diseases and Transplantation, Oslo, Norway;(2)Oslo University Hospital, Research Institute of Internal Medicine- Division of Surgery- Inflammatory Diseases and Transplantation, Oslo, Norway;(3)University of Oslo, Institute of Clinical Medicine- Faculty of Medicine, Oslo, Norway;(4)Bio-Me, Bio-Me, Oslo, Norway;(5)Oslo University Hospital, Department of Gastroenterology, Oslo, Norway;(6)Örebro University, School of Medical Sciences, Örebro, Sweden;(7)Örebro University, Department of Gastroenterology- Faculty of Medicine and Health, Örebro, Sweden;(8)Christian-Albrechts-University of Kiel, Institute of Clinical Molecular Biology, Kiel, Germany;(9)University of Oslo, University of Oslo, Oslo, Norway;(10)Akershus University Hospital, Department of Gastroenterology, Lørenskog, Norway;(11)Telemark Hospital, Department of Gastroenterology, Skien, Norway;(12)Lovisenberg Diaconal Hospital, Unger-Vetlesen Insitute, Oslo, Norway;(13)University of Oslo, Department of Public Health- Institute of Health and Society, Oslo, Norway;(14)Oslo University Hospital, Pediatric Department, Oslo, Norway;(15)Innlandet Hospital Trust, Medical Department, Oslo, Norway;(16)Diakonhjemmet Hospital, Department of Medicine, Oslo, Norway;(17)Østfold Hospital Trust, Department of Gastroenterology, Grålum, Norway;(18)Innlandet Hospital Trust, Department of Medicine, Gjøvik, Norway;(19)Sørlandet Hospital Flekkefjord, Department of Medicine, Flekkefjord, Norway;(20)Lovisenberg Diaconal Hospital, Department of Medicine/Gastroenterology, Oslo, Norway;(21)Lovisenberg Diaconal Hospital, Unger-Vetlesen Institute, Oslo, Norway;(22)Vestfold Hospital Trust, Medical Department, Tønsberg, Norway;(23)Oslo University Hospital, Section of Gastroenterology- Department of Transplantation Medicine- Division of Surgery- Inflammatory Diseases and Transplantation, Oslo, Norway;
P921: FMT in UC is associated with a decrease in Bacteroides-2 enterotype and response with baseline RNA and microbiota signaturesECCO’23 CopenhagenYear: 2023
Authors: Deleu, S.(1)*;Caenepeel , C.(1);Verstockt, S.(1);Vazquez Castellanos, J.F.(2,3);Arnauts , K.(1);Braekeleire, S.(1);Machiels, K.(1);Baert, F.(4);Mana, F.(5);Pouillon, L.(6);Hindryckx, P.(7);Lobaton Ortega, T.(7);Louis, E.(8);Franchimont, D.(9);Verstockt , B.(1,10);Ferrante, M.(1,10);Sabino, J.(1,10);Vieira-Silva, S.(2,11,12);Falony, G.(2,3,13);Raes, J.(2,3);Vermeire, S.(1,10);
(1)KU Leuven, Department of Chronic Diseases- Metabolism & Ageing CHROMETA, Leuven, Belgium;(2)KU Leuven, Department of Microbiology and Immunology, Leuven, Belgium;(3)VIB, Center for microbiology, Leuven, Belgium;(4)AZ Delta, Department of Gastroenterology and Hepatology, Roeselare, Belgium;(5)University Hospitals Brussels, Department of Gastroenterology and Hepatology, Brussels, Belgium;(6)Imelda, Department of Gastroenterology and Hepatology, Bonheiden, Belgium;(7)University Hospital Gent, Department of Gastroenterology and Hepatology, Gent, Belgium;(8)CHU Liège, Department of Gastroenterology and Hepatology, Liège, Belgium;(9)Erasmus Hospital Brussels, Department of Gastroenterology and Hepatology, Brussels, Belgium;(10)University Hospital Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(11)Institute of Molecular Biology IMB, Institute of Molecular Biology IMB, Mainz, Germany;(12)University Medical Center of the Johannes Gutenberg-University Mainz, Institute of Medical Microbiology and Hygiene and Research Center for Immunotherapy FZI, Mainz, Germany;(13)University Medical Center of the Johannes Gutenberg-University Mainz, Institute of Medical Microbiology and Hygiene and Research Center for Immunotherapy FZI, Mainz, Belgium;
P922: Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridium difficile infectionECCO’23 CopenhagenYear: 2023
Authors: Yu, S.(1)*;Ge, X.(2);Tan, B.(1);Tian, B.(1);Shi, Y.(1);Dai, Y.(1);Hu, S.(3);Li, Y.(1);Qian, J.(1);
(1)Peking Union Medical College Hospital- Peking Union Medical College and Chinese Academy of Medical Sciences, Department of Gastroenterology, Beijing, China;(2)Institute of Microbiology- Chinese Academy of Sciences, Microbial Resource and Big Data Center, Beijing, China;(3)Institute of Microbiology- Chinese Academy of Sciences, State Key Laboratory of Microbial Resources, Beijing, China;
P923: The pre-treatment gut microbiome at adult IBD inception: Initial signals from the Birmingham inception cohortECCO’23 CopenhagenYear: 2023
Authors: Rimmer, P.(1)*;Cheesbrough, J.(1);Iqbal, A.(2);Sharma, N.(1);Iqbal, T.(1);Quraishi, N.(1);
(1)University Hospitals Birmingham NHS Foundation Trust, Gastroenterology, Birmingham, United Kingdom;(2)University of BIrmingham, Institute of Cardiovascular Sciences, Birmingham, United Kingdom;
P925: Deep functional assessment of the colonic mucosa-associated microbiota in Crohn's disease and health identifies pro- and anti- inflammatory secretomes and associated bacterial consortia. The ENIGMA study.ECCO’23 CopenhagenYear: 2023
Authors: Teh, J.J.(1);Kang, S.(1);Zhang, J.(2,3,4);Hu, J.(2,3,4);Hamilton, A.L.(5,6);Wilson-O'Brien, A.(5,6);Trakman, G.L.(5,6);Lin, W.(2,3,4);Ching, J.(2,4);Sung, J.J.Y.(7);Yu, J.(2,4);Ng, S.C.(2,3,8);Kamm, M.A.(5,6)*;Morrison, M.(1);
(1)University of Queensland, Frazer Institute, Woolloongabba, Australia;(2)The Chinese University of Hong Kong, Department of Medicine and Therapeutics, Hong Kong, China;(3)Microbiota I-Center, MagIC, Hong Kong, China;(4)Li Ka Shing Institute of Health Sciences, State Key Laboratory of Digestive Disease, Hong Kong, China;(5)Saint Vincent's Hospital, Department of Gastroenterology, Melbourne, Australia;(6)University of Melbourne, Department of Medicine, Melbourne, Australia;(7)Nanyang Technological University, Lee Kong Chian School of Medicine, Singapore, Singapore;(8)The Chinese University of Hong Kong, Center for Gut Microbiota Research, Hong Kong, China;
P926: Blautia Obeum Aggravates Colitis in a Murine ModelECCO’23 CopenhagenYear: 2023
Authors: Lee, C.(1,2)*;Koh, S.J.(1,2);Hong, H.T.(1,2);Park, H.(2,3);Im, J.P.(1);Kim, J.S.(1);
(1)Seoul National University College of Medicine, Department of Internal Medicine and Liver Research Institute, Seoul, Korea- Republic Of;(2)Seoul National University College of Medicine, Laboratory of Intestinal Mucosa and Skin Immunology, Seoul, Korea- Republic Of;(3)SMG-SNU Boramae Medical Center, Department of Dermatology, Seoul, Korea- Republic Of;
P927: Corticosteroid treatment in pediatric IBD patients reshapes the gut microbiotaECCO’23 CopenhagenYear: 2023
Authors: Singh , P.(1);Sundararajan, S.(2);Terranegra, A.(1);Elawad, M.(2);Akobeng, A.(2);Al Khodor, S.(1)*;
(1)Sidra Medicine, Research, Doha, Qatar;(2)Sidra Medicine, Pediatrics Gastroenterology- Hepatology and Nutrition, Doha, Qatar;
P928: Identification of mucosal microbiome-host gene interactions in ulcerative colitis patientsECCO’23 CopenhagenYear: 2023
Authors: Namjoo, K.(1)*;Beom Jae Prof. Dr., L.(2);Jeong-An , G.(3);Seung Han, K.(1);Moon Kyung , J.(1);Jong-Jae , P.(1);
(1)Korea University Medical Center- Seoul- Korea- Republic Of., Department of Gastroenterology-, Seoul, Korea- Republic Of;(2)Korea University Medical Center, Department of Gastroenterology, Seoul, Korea- Republic Of;(3)Korea University Guro Hospital- Seoul- Republic of Korea, Medical Science Research Center, Seoul, Korea- Republic Of;
P929: Gut mucosal microbiota composition in Inflammatory Bowel Disease introduced to infliximabECCO’23 CopenhagenYear: 2023
Authors: Ventin-Holmberg, R.(1)*;Lindholm, J.(2);Eberl, A.(3);Taina, S.(3);Saavalainen, P.(4);
(1)University of Helsinki- Human Microbiome Research Program, Faculty of Medicine, Helsinki, Finland;(2)Folkhälsan research center, Folkhälsan research center, Helsinki, Finland;(3)Department of Gastroenterology- Helsinki University Hospital and University of Helsinki, Department of Gastroenterology- Helsinki University Hospital and University of Helsinki, Helsinki, Finland;(4)Folkhälsan Research Center- Translational Immunology Research Program, Folkhälsan Research Center- Translational Immunology Research Program, Helsinki, Finland;
DOP01: A multi-centre study to explore the prevalence of Inflammatory Bowel Disease indicators in patients with moderate- to- severe psoriasis: Baseline results from the EPIC studyECCO'22Year: 2022
Authors: Hayee, B.(1);Ghosh, S.(2);Carter, B.(3);Bartlett, S.(4);Powles, E.(4);Millward, R.(4);Watcham, S.(4);Blanthorn-Hazell, S.(4);Crooks, J.(4);Hansell, C.(4);Millar, J.(5);Williams, C.(5);Migas, S.(5);Hajne, J.(5);Warren, R.(6);
(1)King's College Hospital NHS Foundation Trust, Gastroenterology, London, United Kingdom;(2)Cork University Hospital, Inflammatory Bowel Disease and Immunopathogenesis, County Cork, Ireland;(3)King's College London, Biostatistics and Health Informatics- Institute of Psychiatry- Psychology & Neuroscience, London, United Kingdom;(4)AbbVie Ltd., Medical, Maidenhead, United Kingdom;(5)NorthWest EHealth Limited, Data Analytics, Manchester, United Kingdom;(6)Salford Royal NHS Foundation Trust- Manchester NIHR BRC- University of Manchester, Dermatology, Manchester, United Kingdom;
DOP02: Increasing incidence of Inflammatory Bowel Disease in a high prevalence country: A nationwide study in FinlandECCO'22Year: 2022
Authors: Kontola, K.(1);Oksanen, P.(2,3);Huhtala, H.(4);Jussila, A.T.(2);
(1)The Hospital District of South Ostrobothnia, Department of Internal Medicine, Seinäjoki, Finland;(2)Tampere University Hospital, Department of Gastroenterology and Alimentary Tract Surgery, Tampere, Finland;(3)Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland;(4)Tampere University, Faculty of Social Sciences, Tampere, Finland;
DOP03: The use and efficacy of biological therapies 2010-2020 for Inflammatory Bowel Disease in a Danish tertiary centreECCO'22Year: 2022
Authors: Wewer, M.D.(1);Arp, L.(1);Melek, S.(1);Oluf Krautwald, F.(1);Vind, I.(1);Pedersen, G.(1);Nielsen, A.M.(1);Kiszka-Kanowitz, M.(1);Boysen, T.(1);Theede, K.(1);Nordgaard-Lassen, I.(1);Bendtsen, F.(1);Burisch, J.(1);
(1)Hvidovre Hospital, Gastro unit medical department, Copenhagen, Denmark;
DOP04: Inflammatory Bowel Disease (IBD) and Solid Organ Transplantation. Natural history of pre-existing and de novo IBD patients. (EITOS study of GETECCU)ECCO'22Year: 2022
Authors: Bastón Rey, I.(1);Calvino Suárez, C.(1);Luque, A.M.(2);Caballol, B.(3);Soutullo, C.(4);Bravo, A.(5);Castaño, A.(6);Gros, B.(7);Bernal, L.(8);Diz Lois, M.T.(9);Alonso Galán, H.(10);Cañete, F.(11);Castro, B.(12);Pérez Galindo, P.(13);González Muñoza, C.(14);El Hajra, I.(15);Martínez Montiel , P.(16);Alonso Abreu, I.(17);Mesonero, F.(18);González Vivo, M.(19);Peries, L.(20);Martín Arranz, E.(21);Abril, C.(22);Marín Jiménez, I.(23);Baltar, R.(24);Vicuna, M.(25);Moreno, N.(26);Brunet, E.(27);Rubín de Célix, C.(28);Fajardo, I.(29);Cruz, N.(30);Rojas Feria, M.(2);Fernández Clotet, A.(3);Gimeno, M.(4);Zabana, Y.(31);Suárez Ferrer, C.(21);Rodríguez Lago, I.(32);Barreiro de Acosta, M.(1);
(1)Hospital Clínico Universitario de Santiago De Compostela, Gastroenterology Department, Santiago De Compostela, Spain;(2)Hospital Universitario Virgen del Rocío, Gastroenterology Department, Sevilla, Spain;(3)Hospital Clinic de Barcelona, Gastroenterology Department, Barcelona, Spain;(4)Hospital Universitario y Politécnico La Fe, Gastroenterology Department, Valencia, Spain;(5)Hospital Regional Universitario de Málaga, Gastroenterology Department, Málaga, Spain;(6)Hospital Universitario Central de Asturias, Gastroenterology Department, Oviedo, Spain;(7)Hospital Universitario Reina Sofía, Gastroenterology Department, Córdoba, Spain;(8)Hospital General de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante ISABIAL, Gastroenterology Department, Alicante, Spain;(9)Complexo Hospitalario Universitario A Coruña, Gastroenterology Department, A Coruña, Spain;(10)Hospital Universitario Donostia and Biodonostia Health Research Institute, Gastroenterology Department, San Sebastián- Gipuzkoa, Spain;(11)Hospital Universitari Germans Trias i Pujol. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology Department, Barcelona, Spain;(12)Hospital Universitario Marqués de Valdecilla, Gastroenterology Department, Santander, Spain;(13)Complexo Hospitalario Universitario de Pontevedra, Gastroenterology Department, Pontevedra, Spain;(14)Hospital Santa Creu i Sant Pau, Gastroenterology Department, Barcelona, Spain;(15)Hospital Universitario Puerta de Hierro, Gastroenterology Department, Madrid, Spain;(16)Hospital Universitario 12 de Octubre, Gastroenterology Department, Madrid, Spain;(17)Hospital Universitario de Canarias, Gastroenterology Department, Tenerife, Spain;(18)Hospital Universitario Ramón y Cajal, Gastroenterology Department, Madrid, Spain;(19)Hospital del Mar, Gastroenterology Department, Barcelona, Spain;(20)Hospital Josep Trueta, Gastroenterology Department, Girona, Spain;(21)Hospital Universitario La Paz, Gastroenterology Department, Madrid, Spain;(22)Hospital Clínico Universitario de Valencia, Gastroenterology Department, Valencia, Spain;(23)Hospital General Universitario Gregorio Marañón, Gastroenterology Department, Madrid, Spain;(24)Hospital Universitario de Álava, Gastroenterology Department, Vitoria, Spain;(25)Complejo Hospitalario Universitario de Navarra, Gastroenterology Department, Navarra, Spain;(26)Hospital Doctor Peset, Gastroenterology Department, Valencia, Spain;(27)Hospital Universitari Parc Taulí, Gastroenterology Department, Sabadell, Spain;(28)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-IP, Gastroenterology Department, Madrid, Spain;(29)Hospital Universitari Mútua Terrasa, Gastroenterology Department, Barcelona, Spain;(30)Hospital Doctor José Molina Orosa, Gastroenterology Department, Lanzarote, Spain;(31)Hospital Universitari Mútua Terrasa. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology Department, Barcelona, Spain;(32)Hospital Universitario de Galdakao and Biocruces Bizkaia Health Research Institute, Gastroenterology Department, Galdakao, Spain;young GETECCU group
DOP05: Morbid obesity, a new susceptibility factor for developing Inflammatory Bowel Disease. Results of a population-based studyECCO'22Year: 2022
Authors: Canete Pizarro, F.C.(1);Vela, E.(2);Calafat, M.(1);Clèries, M.(2);Mañosa, M.(1);Domènech, E.(1);
(1)Germans Trias i Pujol University Hospital and CIBEREHD, Gastroenterology, Badalona, Spain;(2)Servei Català de la Salut- Generalitat de Catalunya, Unitat d’Informació i Coneixement, Barcelona, Spain;
DOP06: Antibiotics as a risk factor for older onset IBD: A population-based cohort studyECCO'22Year: 2022
Authors: Faye, A.(1);Allin, K.(2);Iversen, A.(2);Agrawal, M.(3);Faith, J.(4);Jean-Frederic , C.(3);Jess, T.(2);
(1)NYU Langone Health, Medicine, New York City, United States;(2)Aalborg University, Medicine, Copenhagen, Denmark;(3)Icahn School of Medicine- Mount Sinai Hospital, Medicine, New York City, United States;(4)Icahn School of Medicine- Mount Sinai Hospital, Genetics and Genomics Science, New York City, United States;
